Digital Pathology Podcast
Aleksandra Zuraw from Digital Pathology Place discusses digital pathology from the basic concepts to the newest developments, including image analysis and artificial intelligence. She reviews scientific literature and together with her guests discusses the current industry and research digital pathology trends.
Episodes
What if the way we quantify pathology is more guesswork than science? In this episode of DigiPath Digest, I take you through the latest research where AI is not just supporting but challenging traditional methods of image analysis in neuropathology, nephrology, hematology, and cytology. From Boston brain banks to Mayo Clinic kidney models, we look at how advanced AI compares to human vision—and where it already outper...
What if the AI tools we trust for cancer diagnosis are not always correct? This episode of DigiPath Digest takes on the uncomfortable but critical question: can AI “lie” to us—and how do we verify its performance before adopting it in clinical practice?
Highlights:
- [00:02:00] Foundation models in action: Deployment of a fine-tuned pathology foundation model for EGFR biomarker detection in lung cancer—reducing the ne...
What if AI could predict cancer outcomes better than traditional methods—and at a fraction of the cost? In this episode, I explore how multimodal AI is reshaping lung and prostate cancer predictions and why integration challenges still stand in the way.
Episode Highlights with Timestamps:
- [00:02:57] Agentic AI in toxicologic pathology – what it is and how it could orchestrate workflows.
- [00:05:40] Grandium desktop sc...
“AI in Pathology Isn’t Coming — It’s Already Here. Are You Ready?”
From confusion to clarity — that’s what this episode is all about. I sat down with Drs. Liron Pantanowitz, Hooman Rashidi, and Matthew Hanna to dissect one of the most important and comprehensive AI-in-pathology resources ever created: the 7-part Modern Pathology series from UPMC’s Computational Pathology & AI Center of Excellence (CPAiCE). This isn...
Can AI Grade Cancer Better Than Us? The Truth About T-Cell Imaging, Biomarkers & Digital Pathology Disruption
You think Saturday mornings are for coffee? Try diving into bone marrow morphology, organ donor kidney biopsies, and AI-driven metastasis detection at sunrise. That’s how I do it—and you’re invited to join.
Welcome to another data-packed episode of DigiPath Digest, where we explore the latest f...
AI Pathology & Genomics: A New Benchmark for Predicting Gene Mutations
If you still think visual quantification is “good enough” in pathology, think again.
In this 27th episode of DigiPath Digest, I break down four transformative abstracts that show how AI is shifting our diagnostic landscape—from breast cancer segmentation to fibrosis assessment, and all the way to spatial immunology and the evolving immunosc...
If our visual scoring is still based on gut feeling, how do we scale precision?
In this week’s DigiPath Digest, I explored four new AI-focused papers that could reshape how we diagnose prostate, bladder, gastroesophageal, and endocrine cancers.
From automated IHC scoring to predicting urethral recurrence post-cystectomy, these studies highlight the growing value—and responsibility—of integrating AI into our pathol...
If we don’t learn to work with LLMs now, we might end up competing with them. 🧠
In this week’s DigiPath Digest, I return to our Journal Club to unpack the latest research on AI in tumor classification, focusing on GPT-4o, LLaMA, and other LLMs. Can these models really outperform traditional tools when analyzing pathology reports?
Surprisingly—yes. But don’t panic. This episode is about understanding what LLMs act...
AI in Pathology: ML-Ops and the Future of Diagnostics
What if the most advanced AI models we’re building today are doomed to die in the machine learning graveyard? 🤯 That’s the haunting question I tackled in the final episode of our 7-part series exploring the Modern Pathology AI publications.
In this session, I explored machine learning operations (ML-Ops)—what they mean for digital pathology —and why even the most br...
Can We Ever Eliminate Bias in AI for Pathology?
Every time we think we’ve trained a “neutral” algorithm, we discover our own fingerprints all over it. Our biases. Unconscious. Systemic. Data-driven. And if we ignore them, AI won’t just fail—it will fail patients.
Welcome back, my digital pathology trailblazers! In this sixth episode of our 7-part AI in Pathology series, we tackle one of the most uncomfortable yet necess...
The Most Overlooked Risk in AI for Pathology? It’s Not What You Think…
Welcome, my trailblazing digital pathologists! In this episode, I dive headfirst into the regulatory maze of Artificial Intelligence (AI) in pathology, covering global frameworks, safety risks, ethics, and the future of software as a medical device. While regulation might not be the flashiest part of AI, ignoring it could cost us innovation—or worse...
In this episode sponsored by Epredia, Dr. Anil Parwani explores the transformative journey of digital pathology from basic slide scanning to AI-driven diagnostics. He shares real-world implementation experiences and demonstrates how these technologies are addressing critical challenges in pathology practice.
- Pathology faces increasing demands amid workforce shortages and knowledge explosion
- Digital patholo...
You might be using AI models in pathology without even knowing if they’re giving you reliable results.
Let that sink in for a second—because today, we’re fixing that.
In this episode, I walk you through the real statistics that power—and sometimes fail—AI in digital pathology. It's episode 4 of our AI series, and we’re demystifying the metrics behind both generative and non-generative AI. Why does this matter...
What if I told you the biggest AI breakthroughs in pathology aren’t coming from ChatGPT or generative tools—but from the quiet power of predictive analytics and machine learning?
In this episode, I explore the non-generative side of artificial intelligence in pathology. These are the tools that detect tumors, segment tissue, classify images, and make predictions—without generating a single word.
It’s the third chapter i...
❗️Is synthetic data trustworthy enough to train AI for patient care? It just might be—and that's what both excites and terrifies me. ❗️
Hey trailblazers! In this episode of the Digital Pathology Podcast, I take you through the second part of our AI in Pathology series—this time, we’re focusing on generative AI and how it’s revolutionizing diagnostics, education, and workflow in our field.
From synthetic H&E sli...
Generative vs. Non-Generative AI in Pathology: Why the Difference Matters
If we don’t start defining what kind of AI we’re talking about, we risk letting buzzwords replace real science. 🧠
This is where we begin—at the foundation.
Welcome to the first episode of our 7-part Guided Journey through AI in Pathology, inspired by two must-read articles from Modern Pathology that you’ll want bookmarked forever (links belo...
Will FDA rules disrupt the way we diagnose diseases?
In this episode, I break down a seismic shift in lab medicine: a federal court has vacated the FDA’s controversial rule classifying lab-developed tests (LDTs) as medical devices. This change carries serious implications for innovation, digital pathology, AI-based diagnostics, and small labs across the U.S.
🎧 What You’ll Hear:
- What LDTs are and why they matter for...
You think going digital in pathology just means buying a scanner?
Think again.
In this episode sponsored by Epredia, I sat down with Ryan Davis, Director of Global Business Strategy at Epredia, to talk about what it really takes to implement digital pathology—and why modularity, cytology support, and AI integration are changing the game.
Whether you’re starting your digital journey or scaling up with advanced tech, th...
In this episode, I talk with Tiffany Chen, MD, and Ben Cahoon from Techcyte about Fusion, their new digital pathology platform. Fusion integrates clinical and anatomic pathology workflows, AI algorithms, and electronic health records—all into one streamlined experience.
We explore how Fusion simplifies case management, improves diagnostic accuracy, and brings AI-powered pathology into routine practice. Plus, ...
Why do so many digital pathology tools stall before they ever reach patients?
In this USCAP 2025 special sponsored by Muse Microscopy, I talk with Esther Abels, founder of SolarisRTC, regulatory strategist, and the force behind the first FDA-cleared whole slide imaging system.
We break down what startups and established companies must do from day one to succeedbin getting their devices through ...
Popular Podcasts
Gregg Rosenthal and a rotating crew of elite NFL Media co-hosts, including Patrick Claybon, Colleen Wolfe, Steve Wyche, Nick Shook and Jourdan Rodrigue of The Athletic get you caught up daily on all the NFL news and analysis you need to be smarter and funnier than your friends.
I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
Football’s funniest family duo — Jason Kelce of the Philadelphia Eagles and Travis Kelce of the Kansas City Chiefs — team up to provide next-level access to life in the league as it unfolds. The two brothers and Super Bowl champions drop weekly insights about the weekly slate of games and share their INSIDE perspectives on trending NFL news and sports headlines. They also endlessly rag on each other as brothers do, chat the latest in pop culture and welcome some very popular and well-known friends to chat with them. Check out new episodes every Wednesday. Follow New Heights on the Wondery App, YouTube or wherever you get your podcasts. You can listen to new episodes early and ad-free, and get exclusive content on Wondery+. Join Wondery+ in the Wondery App, Apple Podcasts or Spotify. And join our new membership for a unique fan experience by going to the New Heights YouTube channel now!
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.